Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years
NCT00383383 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 141
Last updated 2006-10-03
Summary
Comparison of adjuvanted hepatitis B vaccine to double dose of Engerix™-B in pre- /haemodialysis patients aged ≥15 years.
Conditions
Interventions
- BIOLOGICAL
-
Hepatitis B adjuvanted vaccine
- BIOLOGICAL
-
Engerix-B
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-12-31
Countries
- Czechia
- Malaysia
- Spain
Study Locations
More Related Trials
-
Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults
NCT00696891 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults
NCT00697853 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response
NCT00197158 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).
NCT00697216 ·Status: COMPLETED ·Phase: PHASE3
-
Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination
NCT00291954 ·Status: COMPLETED ·Phase: PHASE3
-
Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)
NCT00440297 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype
NCT00697749 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B
NCT00698087 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age
NCT00697554 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders
NCT00697931 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y
NCT00696917 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B
NCT00697840 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.
NCT00291941 ·Status: COMPLETED ·Phase: PHASE3
-
Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs
NCT00343915 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615)
NCT00508833 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients
NCT00186836 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents
NCT00697775 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants
NCT00697125 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y
NCT00698555 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients
NCT01933412 ·Status: UNKNOWN ·Phase: PHASE3
-
Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules
NCT00697229 ·Status: COMPLETED ·Phase: PHASE2
-
Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control
NCT00697866 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of HEPLISAV™ a Hepatitis B Virus Vaccine in Adults on Hemodialysis
NCT01195246 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine
NCT00805389 ·Status: COMPLETED ·Phase: PHASE2
-
Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population
NCT03962881 ·Status: UNKNOWN ·Phase: PHASE4